These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31541651)

  • 1. A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease.
    Bellozi PMQ; Gomes GF; da Silva MCM; Lima IVA; Batista CRÁ; Carneiro Junior WO; Dória JG; Vieira ÉLM; Vieira RP; de Freitas RP; Ferreira CN; Candelario-Jalil E; Wyss-Coray T; Ribeiro FM; de Oliveira ACP
    Neuropharmacology; 2019 Dec; 160():107785. PubMed ID: 31541651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.
    Haas LT; Salazar SV; Smith LM; Zhao HR; Cox TO; Herber CS; Degnan AP; Balakrishnan A; Macor JE; Albright CF; Strittmatter SM
    Cell Rep; 2017 Jul; 20(1):76-88. PubMed ID: 28683325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mGluR5 positive allosteric modulator CDPPB inhibits SO₂-induced protein radical formation and mitochondrial dysfunction through activation of Akt in mouse hippocampal HT22 cells.
    Guan DF; Ren PY; Hu W; Zhang YL
    Cell Mol Neurobiol; 2015 May; 35(4):573-83. PubMed ID: 25547390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
    Uslaner JM; Parmentier-Batteur S; Flick RB; Surles NO; Lam JS; McNaughton CH; Jacobson MA; Hutson PH
    Neuropharmacology; 2009; 57(5-6):531-8. PubMed ID: 19627999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mGluR5 positive allosteric modulation prevents MK-801 induced increases in extracellular glutamate in the rat medial prefrontal cortex.
    LaCrosse AL; May CE; Griffin WC; Olive MF
    Neuroscience; 2024 Sep; 555():83-91. PubMed ID: 39019391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.
    Horio M; Fujita Y; Hashimoto K
    Fundam Clin Pharmacol; 2013 Oct; 27(5):483-8. PubMed ID: 22594375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
    J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
    Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.
    Clifton NE; Morisot N; Girardon S; Millan MJ; Loiseau F
    Psychopharmacology (Berl); 2013 Feb; 225(3):579-94. PubMed ID: 22983144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
    Maiti P; Paladugu L; Dunbar GL
    BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical changes underlying cognitive impairment in olfactory bulbectomized rats and the impact of the mGlu
    Płoska A; Cieślik P; Siekierzycka A; Kalinowski L; Wierońska JM
    Brain Res; 2021 Oct; 1768():147577. PubMed ID: 34217728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea attenuates oxidative, metabolic, and excitotoxic stress in rat hippocampal neurons and improves spatial memory in a mouse model of Alzheimer's disease.
    Brose RD; Lehrmann E; Zhang Y; Reeves RH; Smith KD; Mattson MP
    Neurobiol Aging; 2018 Dec; 72():121-133. PubMed ID: 30245242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal and cortical metabotropic glutamate 5 receptor expression and behavioral effects of the positive allosteric modulator CDPPB in a model of DYT1 dystonia.
    Perl S; Richter F; Richter A
    Pharmacol Biochem Behav; 2020 Sep; 196():172977. PubMed ID: 32615137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
    Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
    Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Adolescent CDPPB Treatment Alters Short-Term, but not Long-Term, Glutamatergic Receptor Expression.
    Lum JS; Millard SJ; Frank E; Matosin N; Huang XF; Ooi L; Newell KA
    Neurochem Res; 2018 Aug; 43(8):1683-1691. PubMed ID: 29936568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies.
    Overk CR; Cartier A; Shaked G; Rockenstein E; Ubhi K; Spencer B; Price DL; Patrick C; Desplats P; Masliah E
    Mol Neurodegener; 2014 May; 9():18. PubMed ID: 24885390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.
    Doria JG; Silva FR; de Souza JM; Vieira LB; Carvalho TG; Reis HJ; Pereira GS; Dobransky T; Ribeiro FM
    Br J Pharmacol; 2013 Jun; 169(4):909-21. PubMed ID: 23489026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.